The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Fesenko O.V.

Russian Medical Academy of Continuing Professional Education

No Cigarettes

Authors:

Fesenko O.V.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(10): 54‑61

Read: 145 times

To cite this article:

Fesenko OV. No Cigarettes. Non Nocere. New Therapeutic Journal. 2025;(10):54‑61. (In Russ.)

References:

  1. Hersi M, Beck A, Hamel C, et al. Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews. Syst Rev. 2024 Jul 12;13(1):179.  https://doi.org/10.1186/s13643-024-02570-9
  2. Mons U, Müezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015 Apr 20;350: h1551. https://doi.org/10.1136/bmj.h1551
  3. Pirie K, Peto R, Reeves GK, Green J, Beral V; Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013 Jan 12;381(9861):133-141.  https://doi.org/10.1016/S0140-6736(12)61720-6
  4. NICE. Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline. Reference number: NG209. Published: 30 November 2021. Last updated: 04 February2025. https://www.nice.org.uk/guidance/NG209
  5. Ministry of Health. 2021. The New Zealand Guidelines for Helping People to Stop Smoking: 2021 Update. Wellington: Ministry of Health. https://www.health.govt.nz/system/files/2014-06/the-new-zealand-guidelines-for-helping-people-to-stop-smoking-2021.pdf
  6. Scottish Intercollegiate Guidelines Network (SIGN) (2017). SIGN publication No. 149: Risk estimation and the prevention of cardiovascular disease. Scottish Intercollegiate Guidelines Network (SIGN). https://www.sign.ac.uk/
  7. US Preventive Services Task Force; Krist AH, Davidson KW, et al. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Jan 19;325(3):265-279.  https://doi.org/10.1001/jama.2020.25019
  8. The Royal Australian College of General Practitioners. Supporting smoking cessation: A guide for health professionals (Date of Access: 21.08.2025). https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation/about-this-guideline
  9. Leone FT, Zhang Y, Evers-Casey S, et al. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 Jul 15;202(2):e5–e31.  https://doi.org/10.1164/rccm.202005-1982ST
  10. Gates M, Gates A, Pieper D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022 Aug 9;378:e070849. https://doi.org/10.1136/bmj-2022-070849
  11. Pollock M, Fernandes RM, Newton AS, Scott SD, Hartling L. A decision tool to help researchers make decisions about including systematic reviews in overviews of reviews of healthcare interventions. Syst Rev. 2019 Jan 22;8(1):29.  https://doi.org/10.1186/s13643-018-0768-8
  12. Lunny C, Pieper D, Thabet P, Kanji S. Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews. BMC Med Res Methodol. 2021 Jul 7;21(1):140.  https://doi.org/10.1186/s12874-021-01269-y
  13. Bougioukas KI, Vounzoulaki E, Mantsiou CD, et al. Methods for depicting overlap in overviews of systematic reviews: An introduction to static tabular and graphical displays. J Clin Epidemiol. 2021 Apr;132:34-45.  https://doi.org/10.1016/j.jclinepi.2020.12.004
  14. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016 Jul;75:40-46.  https://doi.org/10.1016/j.jclinepi.2016.01.021
  15. Salagay O.O., Sakharova G.M., Antonov N.S., Tetenova E.Yu., Nadezhdin A.V. Clinical guidelines for the treatment of tobacco dependence syndrome, tobacco withdrawal syndrome. Public Health. 2025;5(2):70-80. (In Russ.) https://doi.org/10.21045/2782-1676-2025-5-2-70-80
  16. Wadgave U, Nagesh L. Nicotine Replacement Therapy: An Overview. Int J Health Sci (Qassim). 2016 Jul;10(3):425-435. 
  17. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl). 1999 Jul;145(1):1-20.  https://doi.org/10.1007/s002130051027
  18. Balfour DJ. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens. Nicotine Tob Res. 2004;6(6):899-912.  https://doi.org/10.1080/14622200412331324965
  19. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71.  https://doi.org/10.1146/annurev.pharmtox.48.113006.094742
  20. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3): CD000146. https://doi.org/10.1002/14651858.CD000146.pub2
  21. Le Foll B, Melihan-Cheinin P, Rostoker G, Lagrue G; Working Group of AFSSAPS. Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur Psychiatry. 2005 Aug;20(5-6):431-441.  https://doi.org/10.1016/j.eurpsy.2004.12.008
  22. Molyneux A, Králíková E, Himmerová V. Abeceda odvykání kourení. Náhradní terapie nikotinem [ABC of smoking cessation. Nicotine replacement therapy]. Cas Lek Cesk. 2004;143(11): 781-783. 
  23. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000 Jun 28;283(24):3244-3254.
  24. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005 Sep–Oct;55(5):281-299; quiz 322-3, 325.  https://doi.org/10.3322/canjclin.55.5.281
  25. Prochaska JJ. Nicotine Replacement Therapy as a Maintenance Treatment. JAMA. 2015 Aug 18;314(7):718-719.  https://doi.org/10.1001/jama.2015.7460
  26. D’Souza MS, Markou A. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract. 2011 Jul;6(1):4-16. 
  27. Torazzi A, Tedesco E, Ceccato S, et al. Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study. Front Public Health. 2024 Sep 30;12:1350176. https://doi.org/10.3389/fpubh.2024.1350176
  28. Guo K, Zhou L, Shang X, et al. Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis. Drug Alcohol Depend. 2022 Dec 1;241:109672. https://doi.org/10.1016/j.drugalcdep.2022.109672
  29. Whitley HP, Moorman KL. Varenicline: A review of the literature and place in therapy. Pharm Pract (Granada). 2007 Apr;5(2):51-58.  https://doi.org/10.4321/s1886-36552007000200001

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.